Clinical trial
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
NCT01641276 is registered in ClinicalTrials.gov with Hospital Sirio-Libanes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
- Lead sponsor
- Hospital Sirio-Libanes
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- June 30, 2015
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis, hepatocellular carcinomas